Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 1
2012 1
2013 4
2014 3
2015 3
2016 2
2017 3
2018 3
2019 7
2020 6
2021 7
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous Infusion of DNA-Aptamer Raised against Advanced Glycation End Products Prevents Loss of Skeletal Muscle Mass and Strength in Accelerated-Aging Mice.
Mori Y, Ohara M, Terasaki M, Osaka N, Yashima H, Saito T, Otoyama-Kataoka Y, Omachi T, Higashimoto Y, Matsui T, Fukui T, Yamagishi SI. Mori Y, et al. Among authors: ohara m. Biomedicines. 2023 Nov 22;11(12):3112. doi: 10.3390/biomedicines11123112. Biomedicines. 2023. PMID: 38137333 Free PMC article.
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study.
Omachi T, Ohara M, Fujikawa T, Kohata Y, Sugita H, Irie S, Terasaki M, Mori Y, Fukui T, Yamagishi SI. Omachi T, et al. Among authors: ohara m. Diabetes Ther. 2024 Jan;15(1):111-126. doi: 10.1007/s13300-023-01493-3. Epub 2023 Oct 25. Diabetes Ther. 2024. PMID: 37880502 Free PMC article.
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Hirano T, et al. Among authors: ohara m. J Diabetes Investig. 2023 Dec;14(12):1401-1411. doi: 10.1111/jdi.14076. Epub 2023 Aug 30. J Diabetes Investig. 2023. PMID: 37647503 Free PMC article. Clinical Trial.
Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Takehana N, Fukui T, Mori Y, Hiromura M, Terasaki M, Ohara M, Takada M, Tomoyasu M, Ito Y, Kobayashi T, Yamagishi SI. Takehana N, et al. Among authors: ohara m. J Diabetes Investig. 2023 Jul;14(7):856-863. doi: 10.1111/jdi.14016. Epub 2023 Apr 20. J Diabetes Investig. 2023. PMID: 37082800 Free PMC article.
Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
Fukui T, Takehana N, Mori Y, Hiromura M, Terasaki M, Kushima H, Takada M, Tomoyasu M, Sato N, Hayashi T, Ohara M, Kikuchi T, Ito Y, Kobayashi T, Yamagishi SI. Fukui T, et al. Among authors: ohara m. Endocr J. 2022 Nov 28;69(11):1343-1349. doi: 10.1507/endocrj.EJ22-0146. Epub 2022 Jun 24. Endocr J. 2022. PMID: 35753761 Free article.
Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
Lee E, Lee S, Tashiro Y, Ogihara M, Watanabe H, Ishibashi S, Nagata S, Miyo K, Ohara M, Otsuki T, Sueki H. Lee E, et al. Among authors: ohara m. J Dermatol. 2022 Jul;49(7):e221-e223. doi: 10.1111/1346-8138.16341. Epub 2022 Mar 3. J Dermatol. 2022. PMID: 35243680 No abstract available.
Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study.
Ohara M, Nagaike H, Fujikawa T, Kohata Y, Ogawa M, Omachi T, Sasajima R, Chiba H, Ara T, Sugawara A, Hiromura M, Terasaki M, Mori Y, Fukui T, Hirano T, Yokoyama H, Yamagishi SI. Ohara M, et al. Diabetes Res Clin Pract. 2021 Sep;179:108999. doi: 10.1016/j.diabres.2021.108999. Epub 2021 Aug 12. Diabetes Res Clin Pract. 2021. PMID: 34390762 Clinical Trial.
47 results